The Alliance Funding: How Much Did They Raise & Key Investors

How Much Did The Alliance Raise?
Funding & Key Investors

The Alliance has successfully secured a significant capital injection, marking a pivotal moment in its operational trajectory. With a total funding amount reaching $350K, the organization continues to solidify its position as a cornerstone of oncology services in the Inland Northwest. This recent funding amount of $350K represents a major strategic investment, underscoring the confidence stakeholders place in the collaborative model established by Providence Health Care, Kootenai Health, and Cancer Care Northwest.

The infusion of capital serves as a catalyst for expanding the reach and efficacy of cancer treatment protocols across the Spokane and Coeur d’Alene regions. By leveraging this financial backing, The Alliance is well-positioned to enhance its clinical infrastructure and streamline patient-centric care delivery.

What is The Alliance?

The Alliance

Organizations

Non-Profit & Charitable Organizations

Membership Organizations

The Alliance functions as a sophisticated collaborative network designed to unify the resources of major regional healthcare providers. By integrating the expertise of Providence Health Care, Kootenai Health, and Cancer Care Northwest, the entity provides a comprehensive ecosystem for oncology treatment. Its market position is defined by its ability to bridge the gap between complex medical research and localized patient care, facilitating seamless referrals and providing robust support systems for both patients and medical practitioners. The organization is fundamentally committed to elevating the standard of cancer care through shared clinical governance and resource optimization.

How much funding has The Alliance raised?

The Alliance has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in The Alliance

PPP

Public-Private Partnership

What's next for The Alliance?

Looking ahead, the strategic deployment of this capital will likely focus on scaling clinical capabilities and integrating advanced diagnostic technologies to improve patient outcomes. As the organization matures within its late-stage lifecycle, the focus will shift toward long-term sustainability and the expansion of its referral network. By maintaining its commitment to collaborative excellence, The Alliance is poised to set new benchmarks for regional healthcare delivery, ensuring that high-quality oncology services remain accessible and effective for the communities it serves. Future initiatives will likely prioritize the modernization of treatment facilities and the further integration of multidisciplinary care teams to address the evolving needs of the oncology landscape.

See full The Alliance company page

See More Financial Insights